Orion Investment CO Blueprint Medicines Corp Transaction History
Orion Investment CO
- $257 Billion
- Q3 2024
A detailed history of Orion Investment CO transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Orion Investment CO holds 108,610 shares of BPMC stock, worth $10.4 Million. This represents 3.91% of its overall portfolio holdings.
Number of Shares
108,610
Previous 108,790
0.17%
Holding current value
$10.4 Million
Previous $11.7 Billion
14.32%
% of portfolio
3.91%
Previous 4.67%
Shares
2 transactions
Others Institutions Holding BPMC
# of Institutions
352Shares Held
60.3MCall Options Held
2.25MPut Options Held
1.18M-
Vanguard Group Inc Valley Forge, PA6.68MShares$638 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.65MShares$634 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.39MShares$514 Million0.06% of portfolio
-
Wellington Management Group LLP Boston, MA3.96MShares$378 Million0.07% of portfolio
-
State Street Corp Boston, MA2.77MShares$264 Million0.01% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $5.7B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...